Order Article Reprints

Rocher G, Gaillard T, Uzan C, Collinet P, Bolze P-A, Ballester M, Bendifallah S, Ouldamer L, Touboul C, Huchon C, et al. Does Time-to-Chemotherapy after Primary Complete Macroscopic Cytoreductive Surgery Influence Prognosis for Patients with Epithelial Ovarian Cancer? A Study of the FRANCOGYN Group. Journal of Clinical Medicine. 2021; 10(5):1058. https://doi.org/10.3390/jcm10051058

Rocher, Grégoire, Thomas Gaillard, Catherine Uzan, Pierre Collinet, Pierre-Adrien Bolze, Marcos Ballester, Sofiane Bendifallah, Lobna Ouldamer, Cyril Touboul, Cyrille Huchon, and et al. 2021. "Does Time-to-Chemotherapy after Primary Complete Macroscopic Cytoreductive Surgery Influence Prognosis for Patients with Epithelial Ovarian Cancer? A Study of the FRANCOGYN Group" Journal of Clinical Medicine 10, no. 5: 1058. https://doi.org/10.3390/jcm10051058

Rocher, G., Gaillard, T., Uzan, C., Collinet, P., Bolze, P.-A., Ballester, M., Bendifallah, S., Ouldamer, L., Touboul, C., Huchon, C., Lavoue, V., Dabi, Y., Akladios, C., Coutant, C., Raimond, E., Bricou, A., Canlorbe, G., & Azaïs, H. (2021). Does Time-to-Chemotherapy after Primary Complete Macroscopic Cytoreductive Surgery Influence Prognosis for Patients with Epithelial Ovarian Cancer? A Study of the FRANCOGYN Group. Journal of Clinical Medicine, 10(5), 1058. https://doi.org/10.3390/jcm10051058